OPK Stock: Price, Earnings History and SEC Filings
OPKO Health, Inc. (OPK) last traded at $1.66, up 0.00% on the latest session and up 3.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.01 against an analyst estimate of $-0.08, a beat of 87.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
OPK earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 27, 2026 | $-0.01 | $-0.08 | +87.50% |
| Mar 2026 | Apr 28, 2026 | $-0.07 | $-0.07 | +0.00% |
| Dec 2025 | Feb 26, 2026 | $-0.04 | $-0.07 | +42.86% |
| Sep 2025 | Oct 29, 2025 | $0.03 | $-0.02 | +250.00% |
OPK beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How OPK reacts to earnings
Across its last 8 earnings releases, OPK moved 8.0% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-07-27 | After close | +33.06% |
| 2026-04-28 | After close | -8.26% |
| 2026-02-26 | After close | +0.00% |
| 2025-10-29 | After close | +2.10% |
| 2025-07-31 | After close | -7.03% |
| 2025-04-30 | After close | -2.17% |
| 2025-02-27 | After close | +6.75% |
| 2024-11-07 | After close | +4.83% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
OPK financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $607M | -$226M | – | -37.2% | $-0.30 |
| 2024 | $713M | -$53M | – | -7.5% | $-0.08 |
| 2023 | $863M | -$189M | – | -21.9% | $-0.25 |
| 2022 | $1.0B | -$328M | – | -32.7% | $-0.46 |
| 2021 | $1.8B | -$30M | – | -1.7% | $-0.05 |
| 2020 | $1.4B | $31M | – | 2.1% | $0.05 |
| 2019 | $902M | -$315M | – | -34.9% | $-0.53 |
| 2018 | $990M | -$153M | – | -15.5% | $-0.27 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for OPK
- 8-K · Oct 15, 2026Material agreement, Financial statements and exhibits
- 8-K · Oct 2, 2026Other events
- 8-K · Aug 14, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 10-Q · Jul 27, 2026
- 8-K · Jul 27, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 18, 2026Shareholder vote
- DEF 14A · Apr 30, 2026
- 10-Q · Apr 28, 2026
- 8-K · Apr 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Mar 19, 2026Officer or director change
Insider filing activity
OPK insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
OPK news
- DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseOct 30, 2026 · finance.yahoo.com
- DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YOct 30, 2026 · finance.yahoo.com
- Reasons to Hold Hinge Health Stock in Your Portfolio for NowOct 29, 2026 · finance.yahoo.com
- Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook RaisedOct 29, 2026 · finance.yahoo.com
- GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View RaisedOct 28, 2026 · finance.yahoo.com
- OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026Oct 28, 2026 · finance.yahoo.com
- Cencora to Acquire AON in $2.4B Deal to Expand Oncology NetworkOct 28, 2026 · finance.yahoo.com
- Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/YOct 27, 2026 · finance.yahoo.com
About OPKO Health, Inc.
OPKO Health, Inc. (OPK) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.